Search results

  1. V.R.T.

    UK: Physios for ME

    Agreed, this would have saved my functioning and kept me from deterioration.
  2. V.R.T.

    News from the USA, United States of America

    I keep seeing people saying locking down to protect the vunerable was a mistake. Because people think only old and disabled people died or got really sick. [*The media and governments during the lockdowns] were saying everyone who died who wasn't elderly had 'pre existing conditions'. But when...
  3. V.R.T.

    News From Jarred Younger / Neuroinflammation, Pain, and Fatigue Laboratory at UAB, From Aug 2020

    The question is why this is necessary at all when there are 2 RCTs for ME/CFS due to report fairly soon? Maybe for replication?
  4. V.R.T.

    Community Symposium on the Molecular Basis of ME/CFS Sept 5 (Stanford/Ron Davis)

    Unfortunately she didn't! Yes I hope we see the paper soon, looking forward to her Charite presentation.
  5. V.R.T.

    Why is showering so PEM/OI inducing

    Just wondering, as someone who barely ever (seated) showers because of it, why people think showering in particular is such a big cause of PEM and OI symptoms. My rationale for this post is it might give some clue as to what's going on with us.
  6. V.R.T.

    Teclistamab for ME/CFS

    I don't think Habets should be doing what he's doing at all, but if he is going to do it he should at least use a dosage of the drug that might have an effect, rather than just cause anti drug effect/immunity. In light of that i think this low dose dara/Teclistamab nonsense is actually more...
  7. V.R.T.

    CAR-T therapy

    Fluge said at Charite an American company was considering a trial in ME/CFS.
  8. V.R.T.

    CAR-T therapy

    If daratumumab turns out to work, perhaps this anti CD38 CAR-T will be the future of ME/CFS treatment https://pmc.ncbi.nlm.nih.gov/articles/PMC10225187/
  9. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    Okay then you have seriously misunderstood. F&M observed massive improvements in cancer patients with ME/CFS following treatment for cancer. So significant they were asking for more chemotherapy. They have followed this clinical observation through several drug trials, including a positive phase...
  10. V.R.T.

    Metabolic adaptation and fragility in healthy 3-D in vitro skeletal muscle tissues exposed to [CFS] and Long COVID-19 sera, 2025, Mughal+

    I'm not a huge fan of Cort's 'everything is true even conflicting things' approach to MECFS science but the below quote sounds quite a good idea to me:
  11. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    If dara turns out to really work like in the pilot it will be close to a silver bullet for at least a subset of pwME. The psychobehavioural school cannot demonstrate any significant improvement at all in a decent trial, let alone anything close to what the dara pilot showed. I fail to see how...
  12. V.R.T.

    Rosetta Stone Study: £1.1m awarded to investigate links between ME/CFS and Long Covid

    On a related note, do we know if Altmann is aware of the CD38 finding in the Mensah/Armstrong/Cambridge study? That might be a good one for him to try and replicate.
  13. V.R.T.

    Video: New insights into CFS and ME : Prof Wirth, Patrick Ussher

    My issue is that Wirth has done no basic research in ME/CFS, has only published hypothesis papers, and has gone straight to drug development. If it turns out to work I'll be over the moon but I can't bring myself to get excited until I see some solid science behind it. This guy Ussher also...
  14. V.R.T.

    Open Norway: Plasma cell aimed treatment with daratumumab in ME/CFS (ResetME) - Haukeland University Hospital

    Where did we land on the possibility of preliminary results being announced/presented before all patients have completed the 72 week monitoring period? I think we were generally of the opinion that the given date of 2029 was probably the worst case scenario for preprint publication, and 2028...
  15. V.R.T.

    Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies... 2025 Ariza et al

    Is it possible that these antibodies are a) pathogenic and b) killed by dara but not rituximab (i.e. anti cd38 but not anti cd20)?
  16. V.R.T.

    Covid-19 vaccination experiences

    Is there currently any way to get an up to date novavax shot in the UK?
  17. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    The thing I'm currently feeling trepidation about is the upcoming severe patient case study. If the severe patients with higher NK cells don't respond I'm going to find that difficult to cope with. Of course a handful of unblinded patients isn't exactly definitive proof but if they react like...
  18. V.R.T.

    Hypotheses and Research Directions for ME/CFS

    Ah right, I think this question was saying could PEM be caused by different things, rather than PEM causes different subtypes of symptoms. As to what you said yes I think were in agreement.
Back
Top Bottom